CVE-2026-118795
Full vulnerability record from the local CVENow database.
Description
Administrative roles and module permissions are stored in mutable local database fields, allowing privilege escalation for attackers with database write access.
Severity
MEDIUM
CVSS score
5.9
(v4.0)
Vulnerability status
Received
Source identifier
a6d3dc9e-0591-4a13-bce7-0f5b31ff6158
Published
2026-11-09 13:17:05.593000
Last modified
2026-11-09 16:17:26.780000
View original CVE JSON
{
"id": "CVE-2026-118795",
"sourceIdentifier": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158",
"published": "2026-11-09T13:17:05.593",
"lastModified": "2026-11-09T16:17:26.780",
"vulnStatus": "Received",
"cveTags": [],
"descriptions": [
{
"lang": "en",
"value": "Administrative roles and module permissions are stored in mutable local database fields, allowing privilege escalation for attackers with database write access."
}
],
"affected": [
{
"source": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158",
"affectedData": [
{
"vendor": "CompuGroup Medical",
"product": "Infantia",
"defaultStatus": "unaffected",
"versions": [
{
"version": "0",
"lessThanOrEqual": "6.09.1",
"versionType": "semver",
"status": "affected"
}
]
},
{
"vendor": "CompuGroup Medical",
"product": "Profim",
"defaultStatus": "unaffected",
"versions": [
{
"version": "0",
"lessThanOrEqual": "6.09.1",
"versionType": "semver",
"status": "affected"
}
]
},
{
"vendor": "CompuGroup Medical",
"product": "Venere",
"defaultStatus": "unaffected",
"versions": [
{
"version": "0",
"lessThanOrEqual": "8.33.2",
"versionType": "semver",
"status": "affected"
}
]
}
]
}
],
"metrics": {
"cvssMetricV40": [
{
"source": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158",
"type": "Secondary",
"cvssData": {
"version": "4.0",
"vectorString": "CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:U/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X",
"baseScore": 5.9,
"baseSeverity": "MEDIUM",
"attackVector": "LOCAL",
"attackComplexity": "LOW",
"attackRequirements": "NONE",
"privilegesRequired": "LOW",
"userInteraction": "NONE",
"vulnConfidentialityImpact": "HIGH",
"vulnIntegrityImpact": "HIGH",
"vulnAvailabilityImpact": "HIGH",
"subConfidentialityImpact": "NONE",
"subIntegrityImpact": "NONE",
"subAvailabilityImpact": "NONE",
"exploitMaturity": "UNREPORTED",
"confidentialityRequirement": "NOT_DEFINED",
"integrityRequirement": "NOT_DEFINED",
"availabilityRequirement": "NOT_DEFINED",
"modifiedAttackVector": "NOT_DEFINED",
"modifiedAttackComplexity": "NOT_DEFINED",
"modifiedAttackRequirements": "NOT_DEFINED",
"modifiedPrivilegesRequired": "NOT_DEFINED",
"modifiedUserInteraction": "NOT_DEFINED",
"modifiedVulnConfidentialityImpact": "NOT_DEFINED",
"modifiedVulnIntegrityImpact": "NOT_DEFINED",
"modifiedVulnAvailabilityImpact": "NOT_DEFINED",
"modifiedSubConfidentialityImpact": "NOT_DEFINED",
"modifiedSubIntegrityImpact": "NOT_DEFINED",
"modifiedSubAvailabilityImpact": "NOT_DEFINED",
"Safety": "NOT_DEFINED",
"Automatable": "NOT_DEFINED",
"Recovery": "NOT_DEFINED",
"valueDensity": "NOT_DEFINED",
"vulnerabilityResponseEffort": "NOT_DEFINED",
"providerUrgency": "NOT_DEFINED"
}
}
],
"ssvcV203": [
{
"source": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
"ssvcData": {
"timestamp": "2026-11-09T15:04:53.696870Z",
"id": "CVE-2026-118795",
"options": [
{
"exploitation": "none"
},
{
"automatable": "no"
},
{
"technicalImpact": "total"
}
],
"role": "CISA Coordinator",
"version": "2.0.3"
}
}
]
},
"weaknesses": [
{
"source": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158",
"type": "Secondary",
"description": [
{
"lang": "en",
"value": "CWE-602"
}
]
}
],
"references": [
{
"url": "https://www.acn.gov.it/portale/w/rilevate-vulnerabilita-in-prodotti-compugroup-medical",
"source": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158"
},
{
"url": "https://www.cgm.com/ita_it/magazine/articles/comunicati-stampa/piu-sicurezza-per-farmacie-studi-medici-e-pazienti-cgm-italia-risolve-potenziali-vulnerabilita-software-insieme-a-csirt-italia.html",
"source": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158"
}
]
}